Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral pantoprazole maintenance therapy in pediatric healed erosive esophagitis
2023-508770-28-00Phase 2Completed
- Sponsor
- Pfizer
- Start
- Dec 2023
- Modality
- Small Molecules
- Countries
- 10
01
Overview
Phase 2, randomised, double-blind trial of pantoprazole in erosive esophagitis (EE) (3 arms), sponsored by Pfizer. Primary endpoint: Endoscopically confirmed maintenance of healing of erosive esophagitis at Week 24. Started Dec 2023; status: completed.
02
Drugs
pantoprazole
03
Conditions
erosive esophagitis (EE)
Beyond the preview
Go deeper on 2023-508770-28-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-508770-28-00.